[
  {
    "ts": null,
    "headline": "Quest Diagnostics Inc. stock underperforms Friday when compared to competitors",
    "summary": "Quest Diagnostics Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=7b0626d03ba5791e973bba0991b207d03da36f99849fe939b6d4a8003fbb8268",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755882240,
      "headline": "Quest Diagnostics Inc. stock underperforms Friday when compared to competitors",
      "id": 136554099,
      "image": "",
      "related": "DGX",
      "source": "MarketWatch",
      "summary": "Quest Diagnostics Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=7b0626d03ba5791e973bba0991b207d03da36f99849fe939b6d4a8003fbb8268"
    }
  },
  {
    "ts": null,
    "headline": "Is Quest Diagnostics Set for Growth After Strong 21% Rally in 2025?",
    "summary": "Thinking about what to do with Quest Diagnostics stock? You are far from alone. With the healthcare sector still buzzing and diagnostic testing remaining essential, investors are keeping close tabs on DGX, especially after its impressive run. Over the past year, Quest Diagnostics has delivered a total return over 22%, with even stronger gains visible across three and five years. If you zoom out, the stock is up nearly 85% in five years, which is no small feat in today’s volatile...",
    "url": "https://finnhub.io/api/news?id=72119c56eae82460156197a7ed737d643b6a3feca68711994a169807bc359b4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755857752,
      "headline": "Is Quest Diagnostics Set for Growth After Strong 21% Rally in 2025?",
      "id": 136477146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Thinking about what to do with Quest Diagnostics stock? You are far from alone. With the healthcare sector still buzzing and diagnostic testing remaining essential, investors are keeping close tabs on DGX, especially after its impressive run. Over the past year, Quest Diagnostics has delivered a total return over 22%, with even stronger gains visible across three and five years. If you zoom out, the stock is up nearly 85% in five years, which is no small feat in today’s volatile...",
      "url": "https://finnhub.io/api/news?id=72119c56eae82460156197a7ed737d643b6a3feca68711994a169807bc359b4c"
    }
  }
]